Examples of using Efficacy endpoints in English and their translations into Dutch
{-}
-
Medicine
-
Colloquial
-
Official
-
Ecclesiastic
-
Financial
-
Computer
-
Ecclesiastic
-
Official/political
-
Programming
Efficacy endpoints for the docetaxel arms versus the control arm are summarized in the following table.
Sensitivity analyses of main efficacy endpoints were also assessed on the Protocol Qualified(PQ) population.
Primary Efficacy Endpoints The primary endpoint of the trial was the skeletal morbidity period rate SMPR.
Primary Efficacy Endpoints The primary endpoint of the trials was the skeletal morbidity period rate SMPR.
Clinical results at week 52 Clinical and virological efficacy endpoints were evaluated separately in the HBeAg-positive
Efficacy endpoints for the docetaxel arms versus the control arm are summarized in the following table.
Secondary efficacy endpoints included time to disease progression(TTP)
Secondary efficacy endpoints included overall survival(OS),
Table 16: Analysis of the primary and secondary efficacy endpoints(VTE is a composite of DVT and/or PE)
Data collected in the post-marketing phase will also be examined to determine if a suitable Naglazyme maintenance dose can be recommended relative to the efficacy endpoints used in the clinical studies.
Additional analyses suggest that the surgical procedure type did not influence the trends in efficacy endpoints and the efficacy of IONSYS was similar across the range of body mass indices studied< 25 to> 40 kg/m2 Body Mass Index.
Primary efficacy endpoints were haemoglobin stabilization(patients who maintained a haemoglobin concentration above the haemoglobin set-point
Table 14: Analysis of the primary and secondary efficacy endpoints(VTE is a composite of DVT and/or PE)
Table 15: Analysis of the primary and secondary efficacy endpoints(VTE is a composite of DVT and/or PE)
major secondary efficacy endpoints.
PGI-I responder rates) efficacy endpoints in a double-blind placebo-controlled trial including a total of 539 patients with early Parkinson's disease.
PGI-I responder rates) efficacy endpoints in a double-blind placebo-controlled trial including a total of 539 patients with early Parkinson's disease.
Secondary efficacy endpoints showed significant reductions in the Synagis group compared to placebo in total days of RSV hospitalisation(56% reduction,
based on investigator assessment using RECIST 1.0. Secondary efficacy endpoints included OS(overall survival),
the key secondary(off-time) efficacy endpoints.